Media

Oncopeptides receives first order of Pepaxti in Italy

HelloBetter Secures Over €6 Million to Accelerate International Expansion and AI Development

Hemab Therapeutics Announces Start of Velora Pioneer, a Phase 1/2 Clinical Trial Investigating HMB-002 for the Treatment of Von Willebrand Disease

Vicore Pharma Holding AB – Year-end report 2024

Oncopeptides publishes year-end report 2024

Adcendo ApS Announces U.S. FDA Clearance of IND Application for Phase I Tiffany-01 Trial of ADCE-T02

Oncopeptides – Strong real-world efficacy and safety data with Pepaxti published in the European Journal of Haematology

BONESUPPORT HOLDING AB (publ) – publishes year end report 2024

Oncopeptides – Invitation to presentation of the year-end report 2024

Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results